Tranexamic Acid for Melasma: What the Research Actually Shows

Last updated: June 2026

Medical Disclaimer: This article is for information only and is not medical advice. Melasma is a medical skin condition, so see a board-certified dermatologist for diagnosis and a treatment plan. Oral tranexamic acid is a prescription drug that requires medical supervision and screening for clotting risk before use. Always patch-test any new topical before applying it to your whole face.

Affiliate Disclosure: We may earn a commission on product links. Our picks stay independent and evidence-led.

Melasma is stubborn. Those brown or gray-brown patches on the cheeks, forehead, and upper lip come back again and again. For years, hydroquinone was the only real answer. Then dermatologists noticed something odd.

Tranexamic acid is an old drug. Doctors have used it for decades to stop heavy bleeding. But patients taking it for bleeding disorders started showing lighter skin. That accident launched one of the most studied melasma treatments of the past decade.

Below, we walk through what the trials actually found. Routes, doses, safety, and how it stacks up against hydroquinone.

Does tranexamic acid actually work for melasma?

Yes. A 2024 meta-analysis of 22 randomized controlled trials with 1,280 patients found that tranexamic acid significantly lowered melasma severity scores (MASI and its variants) across every delivery route (J Dermatolog Treat, 2024). The benefit held up whether TXA was used alone or added to other treatments.

The evidence base is large and consistent. That is rare for a melasma treatment. Most pigment products coast on weak data, but TXA has real RCTs behind it.

Still, results vary by person. Melasma is driven by hormones, sun, and heat, and no drug fixes the cause. Think of TXA as control, not cure.

How does tranexamic acid fade melasma? (mechanism — plasmin, melanocyte signaling)

Tranexamic acid blocks plasminogen from turning into plasmin. Plasmin normally helps release inflammatory and pigment-stimulating signals in the skin, especially after UV exposure. By choking off that pathway, TXA quiets the chain of events that tells melanocytes to crank out melanin.

The drug also calms the blood vessels and mast cells that feed melasma. Melasma is partly a vascular and inflammatory condition, not just a pigment one. That is why a clotting drug ended up working on brown patches.

In short: less plasmin, less melanocyte stimulation, less pigment. It dials down the signal rather than bleaching what is already there.

This mechanism explains a key clinical pattern. Because TXA targets the trigger rather than scrubbing out existing melanin, it works best when paired with strict sun protection. UV light reactivates the plasmin pathway, so unprotected skin keeps feeding the patches faster than TXA can quiet them. The drug and the sunscreen work as a pair, not as rivals.

Topical vs oral tranexamic acid for melasma — which is more effective?

Oral TXA tends to win on raw efficacy. The 2024 meta-analysis ranked oral TXA as the most effective route for cutting MASI, followed by injections, then topical (J Dermatolog Treat, 2024). The trade-off is that oral carries the most safety baggage.

Topical TXA is gentler and safer, but it works more slowly and less dramatically. A microneedling-delivered topical TXA trial found only modest gains over microneedling alone, with no significant difference between the active side and placebo (J Cosmet Dermatol, 2021). Skin penetration is the limiting factor for topicals.

For most people, dermatologists start with topical or combine it with sunscreen and other agents. Oral is reserved for moderate-to-severe cases under supervision. If you want a topical to pair with sun protection, see our tranexamic acid serums research review.

Route comparison

Route	Typical dose	Onset of visible effect	Relative efficacy	Key risk
Oral	250 mg twice daily, 3-6 months	8-12 weeks	Highest (largest MASI drop)	Clotting risk; needs screening
Topical	2-5% cream/serum, twice daily	8-12 weeks	Modest	Mild irritation; patch-test
Intradermal injection	~4-10 mg/mL, every 4 weeks	8-12 weeks	Moderate-high	Pain, bruising, needs a clinic
Microneedling + topical TXA	In-office, monthly	8-12 weeks	Modest add-on to microneedling	Redness, post-inflammatory pigment

What dose of oral tranexamic acid is used for melasma?

The most common regimen is 250 mg twice daily (500 mg total per day) for three to six months. In the landmark 2012 study, 74 patients took 250 mg twice daily for six months, and 64.8% achieved good or excellent results (Aesthetic Plast Surg, 2012). This low dose is far below what is used for bleeding control.

A multicenter dose study tested 500, 750, 1,000, and 1,500 mg per day. All four worked, but there was no significant MASI difference between doses (Eur J Dermatol, 2019). The takeaway: more is not better, so the lowest effective dose makes sense.

Length of treatment matters more than dose size. Improvement tracked with how long patients stayed on it. Never self-dose oral TXA; this is a prescription drug.

Tranexamic acid vs hydroquinone for melasma — what does the evidence say?

In head-to-head trials, they finish close. A split-face study comparing intradermal TXA against 4% hydroquinone cream found that low-concentration TXA (4 mg/mL) trailed hydroquinone, while higher-concentration TXA (10 mg/mL) matched it with no significant difference (Clin Cosmet Investig Dermatol, 2019). Both cut MASI meaningfully from baseline.

Hydroquinone is still the gold-standard topical bleaching agent and often works fastest. But it carries downsides: it can irritate, it should not be used long-term without breaks, and chronic misuse risks a condition called ochronosis. TXA is generally better tolerated for longer use.

Many clinicians now combine them or rotate. TXA suits maintenance; hydroquinone suits short, intense clearing phases. For other comparisons, see our top 10 at-home hyperpigmentation treatments compared.

Study-results snapshot

Study (author, journal)	Route	Dose	n	Outcome	Year
Wu et al., Aesthetic Plast Surg	Oral	250 mg 2x/day, 6 mo	74	64.8% good/excellent response	2012
Zhu et al., Eur J Dermatol	Oral	500-1,500 mg/day	multicenter	All doses effective; no dose difference	2019
Pazyar et al., Clin Cosmet Investig Dermatol	Intradermal vs HQ	4 & 10 mg/mL	49 (split-face)	10 mg/mL TXA = 4% HQ	2019
Arida et al., J Cosmet Dermatol	Microneedling + topical	Split-face vs placebo	20	29% vs 22% MASI drop (NS)	2021
Calacattawi et al. (meta-analysis), J Dermatolog Treat	All routes	Pooled	1,280 (22 RCTs)	Oral > injection > topical for MASI	2024

NS = not statistically significant. HQ = hydroquinone. MASI = Melasma Area and Severity Index.

Is oral tranexamic acid safe? (clotting risk, contraindications)

For most healthy people, low-dose oral TXA is well tolerated, but it is not risk-free. Because TXA is an antifibrinolytic, the central concern is blood clots. The most reported side effects in melasma trials are mild: gastrointestinal upset and lighter periods (Aesthetic Plast Surg, 2012).

Do not take oral TXA if you have a history of clots (DVT, pulmonary embolism, stroke), a clotting disorder, or are pregnant. It also clashes with combined hormonal birth control and hormone therapy, which themselves raise clot risk. Smokers and people with kidney problems need extra caution.

A dermatologist should screen your history and may order labs before prescribing. The 2024 meta-analysis flagged GI discomfort, skin irritation, and menstrual changes as the usual adverse events, with serious events rare in screened patients (J Dermatolog Treat, 2024). Stop the drug and call your doctor if you get leg swelling, chest pain, or shortness of breath.

How long until tranexamic acid fades melasma?

Most people see visible lightening around 8 to 12 weeks. The 2019 dose study found that improvement grew with treatment time, not just dose (Eur J Dermatol, 2019). Patience is part of the protocol.

Many courses run three to six months. After stopping, melasma can creep back, since the underlying triggers remain. In one long-term series, recurrence happened in roughly 1 in 10 patients (Aesthetic Plast Surg, 2012).

Daily broad-spectrum sunscreen is non-negotiable the whole time. UV and visible light undo TXA's work fast. Without sun protection, no melasma treatment holds.

A tinted mineral sunscreen with iron oxides is worth the upgrade for melasma. Plain UV filters miss visible light, which also drives the pigment. Iron oxides block that visible-light wedge that regular sunscreens leave open.

How tranexamic acid fits into a melasma routine

TXA is a teammate, not a solo act. It pairs well with sunscreen, gentle pigment fighters, and barrier care. Layering mechanisms beats hammering one pathway.

Niacinamide blocks pigment transfer to skin cells and calms inflammation, which complements TXA's plasmin blockade; see our best niacinamide serums with clinical evidence. Azelaic acid and gentle exfoliating acids can add fading without harsh bleaching.

Vitamin C adds antioxidant protection against the UV damage that feeds melasma. The form matters for stability and absorption, which we break down in L-ascorbic acid vs ascorbyl glucoside. Build slowly and patch-test each addition.

What TXA can't do

It will not erase melasma for good. The condition is chronic and hormone-linked, so flares return with sun, pregnancy, and heat. Manage expectations.

It also will not replace sun protection. Think of sunscreen as the foundation and TXA as one of several tools stacked on top. Skip the SPF and the drug is wasted.

And it is not a fast bleach. If you need quick clearing before an event, hydroquinone under a dermatologist's care may act faster. TXA rewards consistency over months.

Frequently Asked Questions

Can I buy tranexamic acid over the counter for melasma?

Topical TXA is sold over the counter in serums and creams, usually at 2-5%. Oral TXA is prescription-only and needs a doctor to screen for clotting risk. Never source oral tablets without medical supervision.

How much does oral tranexamic acid lower melasma severity?

Across pooled trials, oral TXA produced the largest drop in MASI scores of any route (J Dermatolog Treat, 2024). In the 2012 study, 64.8% of patients reached a good or excellent result on 250 mg twice daily. Exact reduction varies by patient and trial.

Is tranexamic acid better than hydroquinone?

In head-to-head trials they perform similarly, with higher-concentration TXA matching 4% hydroquinone (Clin Cosmet Investig Dermatol, 2019). Hydroquinone often acts faster, while TXA tends to be better tolerated for longer use. Many dermatologists combine the two.

Does tranexamic acid cause blood clots?

Low-dose oral TXA has a low clot risk in healthy, screened patients, but the risk is not zero. Anyone with a clotting history, clotting disorder, pregnancy, or who uses combined hormonal contraception should avoid it unless a doctor clears them. Seek care for leg swelling, chest pain, or trouble breathing.

How long do I need to take tranexamic acid?

Most melasma courses run three to six months, with visible change around 8-12 weeks (Eur J Dermatol, 2019). Improvement builds with time on treatment. Melasma can return after stopping, so daily sunscreen and maintenance matter.

The Bottom Line

Tranexamic acid earns its reputation. The trial evidence is broad, consistent, and shows real MASI reductions across oral, injected, and topical routes (J Dermatolog Treat, 2024). Oral leads on efficacy; topical leads on safety.

If you are weighing it against hydroquinone, know they finish close in head-to-head trials. TXA shines for longer-term tolerability and maintenance. Hydroquinone still wins on speed for short clearing phases.

Whatever route you choose, two rules hold. Get oral TXA only through a dermatologist who screens your clotting risk, and never skip daily broad-spectrum sunscreen. Melasma is a marathon, and the drug only helps if you protect the finish line.

-- The Exosome Edit Team